| Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study | Lancet, The | 2016 | 903 |
| Drooling in Parkinson's disease: a review | Parkinsonism and Related Disorders | 2014 | 124 |
| Seizure burden in subarachnoid hemorrhage associated with functional and cognitive outcome | Neurology | 2016 | 111 |
| The role of antibody in recovery from alphavirus encephalitis | Immunological Reviews | 1997 | 105 |
| Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia | Clinical Interventions in Aging | 2017 | 96 |
| Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis | Journal of Neurology, Neurosurgery and Psychiatry | 2011 | 85 |
| Designer therapies for glioblastoma multiforme | Annals of the New York Academy of Sciences | 2008 | 83 |
| Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction | Dementia and Geriatric Cognitive Disorders | 2004 | 81 |
| MNGI-14. LONG-TERM OUTCOMES FOLLOWING SURGERY AND/OR RADIATION THERAPY IN PATIENTS WITH HIGH-GRADE MENINGIOMA | Neuro-Oncology | 2017 | 78 |
| MNGI-15. IMPACT OF RADIATION THERAPY ON SURVIVAL OF PATIENTS WITH HIGH-GRADE MENINGIOMAS | Neuro-Oncology | 2017 | 78 |
| Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial | Lancet Neurology, The | 2019 | 74 |
| Diagnosis and treatment of high-grade astrocytoma | Neurologic Clinics | 2007 | 74 |
| Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients | British Journal of Cancer | 2012 | 73 |
| Epilepsy awareness among school teachers in Thailand | Epilepsia | 1999 | 71 |
| Jeavons syndrome existing as occipital cortex initiating generalized epilepsy | Epilepsia | 2011 | 70 |
| Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies | Journal of Neurology, Neurosurgery and Psychiatry | 2016 | 67 |
| Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury | JAMA Neurology | 2016 | 60 |
| The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests | Journal of Alzheimer's Disease | 2016 | 60 |
| Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity | PLoS ONE | 2010 | 59 |
| Camptocormia in Parkinson's disease: definition, epidemiology, pathogenesis and treatment modalities | Journal of Neurology, Neurosurgery and Psychiatry | 2016 | 58 |
| AQP4 antibody-positive Thai cases: clinical features and diagnostic problems | Neurology | 2011 | 57 |
| Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study | Lancet, The | 2018 | 55 |
| Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene | Brain | 2015 | 53 |
| Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma | Journal of Neuro-Oncology | 2011 | 51 |
| Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis | JAMA Neurology | 2020 | 50 |
